See up to 3 months of CLNN. The 7-day demo opens the 1M and 3M ranges and puts CLNN on your watchlist.
Start 7-day demoLatest CLNN insider trades
About Clene Inc. (CLNN)
Clene Inc. files with the SEC under CIK 0001822791 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
CLNN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 681,411 | |
| Other acquisition / disposition | 2 | 799,358 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CLNN insider transactions (Form 4)
4295 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 17,470 | $4.75 | $83K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 15,536 | $5.10 | $79K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 67,991 | $4.88 | $332K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 5,492 | $5.78 | $32K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 7,098 | $5.50 | $39K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 5,319 | $5.40 | $29K | |
| Vallerie McLaughlin - Director | Grant or award | stock option | 3,030 | $0.00 | - | |
| Reed N. Wilcox - Director | Grant or award | stock option | 3,306 | $0.00 | - | |
| Alison Mosca - Director | Grant or award | stock option | 4,201 | $0.00 | - | |
 David J. Matlin - Director | Grant or award | stock option | 5,372 | $0.00 | - | |
| Arjun Jj Desai - Director | Grant or award | stock option | 3,168 | $0.00 | - | |
| Shalom Jacobovitz - Director | Grant or award | stock option | 4,098 | $0.00 | - | |
| Jonathon Gay - Director | Grant or award | stock option | 3,271 | $0.00 | - | |
| Matthew Kiernan - Director | Grant or award | stock option | 2,755 | $0.00 | - | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 5,559 | $4.10 | $23K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 15,284 | $4.32 | $66K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 5,686 | $4.13 | $23K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 3,800 | $4.04 | $15K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 6,418 | $5.02 | $32K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 4,139 | $5.08 | $21K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 8,717 | $4.91 | $43K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 12,665 | $5.32 | $67K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 5,556 | $5.27 | $29K | |
 Morgan R. Brown - Officer | Grant or award | stock option | 35,000 | $0.00 | - | |
| Mark Mortenson - Officer | Grant or award | stock option | 75,000 | $0.00 | - | |
| Robert Dee Etherington - Officer | Grant or award | stock option | 75,000 | $0.00 | - | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 7,923 | $5.13 | $41K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 12,432 | $4.80 | $60K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 12,119 | $5.05 | $61K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 26,105 | $4.89 | $128K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 19,621 | $5.12 | $100K | |
| Chidozie Ugwumba - 10% Owner | Open-market sale | Common Stock | 12,563 | $5.10 | $64K | |
| Matthew Kiernan - Director | Grant or award | stock option | 1,893 | $0.00 | - | |
| Jonathon Gay - Director | Grant or award | stock option | 2,438 | $0.00 | - | |
| Alison Mosca - Director | Grant or award | stock option | 2,887 | $0.00 | - | |
| Shalom Jacobovitz - Director | Grant or award | stock option | 2,816 | $0.00 | - | |
| Arjun Jj Desai - Director | Grant or award | stock option | 2,177 | $0.00 | - | |
| Vallerie McLaughlin - Director | Grant or award | stock option | 2,083 | $0.00 | - | |
| Reed N. Wilcox - Director | Grant or award | stock option | 1,893 | $0.00 | - | |
| David J. Matlin - Director | Grant or award | stock option | 3,692 | $0.00 | - | |
| Mark Mortenson - Officer | Grant or award | stock option | 40,000 | $0.00 | - | |
| Robert Dee Etherington - Officer | Grant or award | stock option | 40,000 | $0.00 | - |
Recent CLNN Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
CLNN insider trading FAQ
What is the latest insider trade for CLNN?
Clene Inc. (CLNN) had 12 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for CLNN runs to 95 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CLNN stock?
No insider purchases of CLNN were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling CLNN stock?
No insider sales of CLNN were filed in the last 90 days. 36 sales are on record for this company.
Where can I see CLNN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CLNN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David J. Matlin view on EDGAR
- - Robert Dee Etherington view on EDGAR
- - Alison Mosca view on EDGAR
- - Matthew Kiernan view on EDGAR
- - Arjun Jj Desai view on EDGAR
- - Alison Mosca view on EDGAR
- - David J. Matlin view on EDGAR
- - Shalom Jacobovitz view on EDGAR
- - Jonathon Gay view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CLNN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CLNN with a 7-day demo
- CLNN on your watchlist
- Every CLNN Form 4 filing on record
- Up to 3 months of CLNN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
